Skip to main content
SpringerLink
Log in

The Beneficial Effect of N-Acetylcysteine and Ciprofloxacin Therapy on the Outcome of Ischemic Fulminant Hepatic Failure

  • Case Report
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lee WM (1994) Acute liver failure. Am J Med 96(Suppl 1A):3S–8S

    Article  PubMed  CAS  Google Scholar 

  2. Mas A, Rodes J (1997) Fulminant hepatic failure. Lancet 349:1081–1085

    Article  PubMed  CAS  Google Scholar 

  3. Gove CD, Hughes RD (1991) Liver regeneration in relationship to acute liver failure. PUBMED: Gut S92–S96

  4. Ryo K, Kamogawa Y, Ikeda I, Yamauchi K, Yonehara S, Nagata S, Hayashi N (2000) Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failure. Am J Gastroenterol 95:2047–2055

    Article  PubMed  CAS  Google Scholar 

  5. Minuk GY, Gautier T (1993) The effect of gamma-aminobutyric acid on hepatic regenerative activity following partial hepatectomy in rats. Gastroenterology 104:217–221

    PubMed  CAS  Google Scholar 

  6. Potter JM, Hickman PE (1992) Cardiodepressant drugs and the high mortality rate associated with ischemic hepatitis. Crit Care Med 20:474–478

    Article  PubMed  CAS  Google Scholar 

  7. Seeto RK, Fenn B, Rocky DC (2000) Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med 109:109–113

    Article  PubMed  CAS  Google Scholar 

  8. Kaymakcalan H, Dourdourekas D, Szanto PB, Steigmann F (1978) Congestive heart failure as cause of fulminant hepatic failure. Am J Med 65:384–388

    Article  PubMed  CAS  Google Scholar 

  9. Shibayama Y (1987) The role of hepatic venous congestion and endotoxaemia in the production of fulminant hepatic failure secondary to congestive heart failure. J Pathol 151:133–138

    Article  PubMed  CAS  Google Scholar 

  10. Liu SL, Degli Esposti S, Yao T, Diehl AM, Zern MA (1995) Vitamin E therapy of acute CCl4-induced hepatic injury in mice is associated with inhibition of nuclear factor kappa B binding. Hepatology 22:1474–1481

    PubMed  CAS  Google Scholar 

  11. Naschitz JE, Slobodin G, Lewis RJ, Zuckerman E, Yeshurun D (2000) Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J 140:111–120

    Article  PubMed  CAS  Google Scholar 

  12. Naschitz JE, Yeshurun D, Shahar J (1990) Cardiogenic hepatorenal syndrome. Angiology 41:893–900

    PubMed  CAS  Google Scholar 

  13. Kisloff B, Schaffer G (1976) Fulminant hepatic failure secondary to congestive heart failure. Am J Dig Dis 21:895–900

    Article  PubMed  CAS  Google Scholar 

  14. Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, Poole-Wilson PA, Coats AJ, Anker SD (1999) Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 353:1838–1842

    Article  PubMed  CAS  Google Scholar 

  15. Cuervas-Mons V, Barrrios C, Garrido A, et al. (1989) Bacterial infections in liver transplant patients under selective decontamination with norfloxacin. Transplant Proc 21:35–58

    Google Scholar 

  16. Tsuji A, Sato H, Kume Y, Tamai I, Okezaki E, Nagata O, Kato H (1988) Inhibitory effects of quinilone antibacterial agents on gamma aminobutyric acid binding to receptor sites in rat brain membranes. Antimicrob Agents Chemother 32:190–194

    PubMed  CAS  Google Scholar 

  17. Minuk GY, Gautier T, Gaharie A, Murphy LJ (1991) The effect of GABA on serum and hepatic polyamine concentration after partial hepatectomy in rats. Hepatology 14:685–689

    Article  PubMed  CAS  Google Scholar 

  18. Kaita DE, Assy N, Gautier T, Zhang M, Meyers A, Minuk GY (1998) The beneficial effects of ciprofloxacin on survival and hepatic regenerative activity in a rat model of fulminant hepatic failure. Hepatology 27:533–536

    Article  PubMed  CAS  Google Scholar 

  19. Harrison P, Keays R, Bray G, Alexander G, Williams R (1990) Improved outcome in paracetamol-induced FHF following late administration of N-acetylcysteine. Lancet 335:1572–1573

    Article  PubMed  CAS  Google Scholar 

  20. Harrison PM, Wendon JA, Gimson AES, Alexander GJM, Williams R (1991) Improvement by acetylcysteine of haemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 324:1852–1857

    Article  PubMed  CAS  Google Scholar 

  21. Devlin J, Ellis AE, McPeake J, Heaton N, Wendon JA, Williams R (1997) N-Acetylcysteine improves indocyanine green extraction and oxygen transport during hepatic dysfunction. Crit Care Med 25:236–242

    Article  PubMed  CAS  Google Scholar 

  22. Spies CD, Reinhart K, Witt I, Meier-Hellmann A, Hannemann L, Bredle DL, Schaffartzik W (1994) Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomised, double-blind study. Crit Care Med 2:1738–1746

    Article  Google Scholar 

  23. Harrison P, Wendon J, Williams R (1996) Evidence of increased guanylate cyclase activation by acetylcysteine in fulminant hepatic failure. Hepatology 23:1067–1072

    Article  PubMed  CAS  Google Scholar 

  24. Zhang H, Spapen H, Nguyen DN, Benlabed M, Buurman WA, Vincent J-L (1994) Protective effects of N-acetyl-L-cysteine in endotoxaemia. Am J Physiol 266:H1745–H1746

    Google Scholar 

  25. Bernard GR, Lucht WD, Niedermeyer ME, Snapper JR, Ogletree ML, Brigham KL (1984) Effect of N-acetyl cysteine on the pulmonary response to endotoxin in the awake sheep and upon in vitro granulocyte function. J Clin Invest 73:1772–1784

    Article  PubMed  CAS  Google Scholar 

  26. Bernard GR (1991) N-Acetylcysteine in experimental and clinical acute Lung injury. Am J Med 91(Suppl 3C):54S–59S

    Article  PubMed  CAS  Google Scholar 

  27. Laurent T, Markert M, Feihl F, Schaller MD, Perret C (1996) Oxidant-antioxidant balance in granulocytes during ARDS: effect of N-acetylcyteine. Chest 109:163–166

    PubMed  CAS  Google Scholar 

  28. Jepsen S, Herlevsen P, Knudsen P, Bud MI, Klausen NO (1992) Antioxidant treatment with N-acetylcysteine during adult respiratory distress syndrome: a prospective, randomised, placebo-controlled study. Crit Care Med 20:918–923

    Article  PubMed  CAS  Google Scholar 

  29. Suter PM, Domenighetti G, Schaller M-D, Laverriere MC, Ritz R, Perret C (1994) N-Acetylcysteine enhances recovery from acute lung injury in man: a randomised, double-blind, placebo-controlled clinical study. Chest 105:190–194

    Article  PubMed  CAS  Google Scholar 

  30. Tepel M, Van Der Giet M, Schwarzfeld C, Laufer UIF, Leirman D, Zidek W (2000) Prevention of radiographic-contrast agent induced reductions in renal function by acetylcysteine. N Engl J Med 343:180–184

    Article  PubMed  CAS  Google Scholar 

  31. Weinbroum AA, Rudick V, Ben-Abraham R, Karchevski E (2000) N-Acetyl-L-cysteine for preventing lung reperfusion injury after liver ischemia-reperfusion: a possible dual protective mechanism in a dose-response study. Transplantation 69:853–859

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Liver Clinic, Sieff Government Hospital, P.O.B. 1008, Safed, 13100, Israel

    Nimer Assy

  2. Department of Internal Medicine A, Sieff Government Hospital, Safed, Israel

    Nimer Assy, Hana Gefen, Sorina Schlesinger & Osamah Hussein

  3. Technion Institute of Technology, Faculty of Medicine, Haifa, Israel

    Nimer Assy & Osamah Hussein

Authors
  1. Nimer Assy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hana Gefen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sorina Schlesinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Osamah Hussein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nimer Assy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Assy, N., Gefen, H., Schlesinger, S. et al. The Beneficial Effect of N-Acetylcysteine and Ciprofloxacin Therapy on the Outcome of Ischemic Fulminant Hepatic Failure. Dig Dis Sci 52, 3507–3510 (2007). https://doi.org/10.1007/s10620-006-9594-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-9594-2

Keywords

Search

Navigation